Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Qué bec City, QC, Canada mAbs constitute an important biological tool for influenza virus haemagglutinin (HA) epitope mapping through the generation of escape mutants, which could provide insights into immune evasion mechanisms and may benefit the future development of vaccines. Several influenza A (H1N1) pandemic 2009 (pdm09) HA escape mutants have been recently described. However, the HA antigenic sites of the previous seasonal A/Brisbane/59/2007 (H1N1) (Bris07) virus remain poorly documented. Here, we produced mAbs against pdm09 and Bris07 HA proteins expressed in human HEK293 cells. Escape mutants were generated using mAbs that exhibited HA inhibition and neutralizing activities. The resulting epitope mapping of the pdm09 HA protein revealed 11 escape mutations including three that were previously described (G172E, N173D and K256E) and eight novel ones (T89R, F128L, G157E, K180E, A212E, R269K, N311T and G478E). Among the six HA mutations that were part of predicted antigenic sites (Ca1, Ca2, Cb, Sa or Sb), three (G172E, N173D and K180E) were within the Sa site. Eight escape mutations (H54N, N55D, N55K, L60H, N203D, A231T, V314I and K464E) were obtained for Bris07 HA, and all but one (N203D, Sb site) were outside the predicted antigenic sites. Our results suggest that the Sa antigenic site is immunodominant in pdm09 HA, whereas the N203D mutation (Sb site), present in three different Bris07 escape mutants, appears as the immunodominant epitope in that strain. The fact that some mutations were not part of predicted antigenic sites reinforces the necessity of further characterizing the HA of additional H1N1 strains.
INTRODUCTION
Influenza viruses possess two major surface glycoproteins, the haemagglutinin (HA) and the neuraminidase (NA) , that are exposed to the host immune system. These proteins determine the antigenic specificities of influenza A viruses allowing their classification into 18 HA (H1-H18) and 11 NA (N1-N11) subtypes (Wu et al., 2014) . Influenza A viruses of the H1N1 subtype, together with H2N2 and H3N2 viruses, have been present in human epidemics and pandemics over the last century. An avian-origin influenza A (H1N1) virus caused the most severe pandemic in 1918 that resulted in .40 million deaths (Reid et al., 2000) . Oseltamivir-resistant influenza A/Brisbane/59/07-like (H1N1) viruses have also been associated with major seasonal influenza epidemics between 2007 and 2009 (Holder et al., 2011) . In April 2009, a swine-origin influenza A (H1N1) pandemic strain (pdm09) emerged causing the first influenza pandemic of the 21st century (CDC, 2009; Cutler et al., 2009; Fraser et al., 2009) . mAbs constitute an important biological tool for epitope mapping through the generation of escape mutants (Caton et al., 1982; Gerhard et al., 1981; Köhler & Milstein, 1975; Lubeck & Gerhard, 1981; Webster et al., 1982) . The characterization of the influenza A HA protein was initially performed using the influenza A/PR/8/1934 (H1N1) reference strain (Caton et al., 1982) . In that report, four major antigenic sites were identified. These included the 'specific' Sa and Sb sites and the 'cross-reactive' Ca and Cb ones. In addition, as Ca is not a contiguous polypeptide in the primary protein structure, it was split into Ca1 and Ca2 regions, which form hypervariable domains into the tertiary globular protein structure. The antigenic sites described for influenza A/PR/8/1934 HA have served as a reference model for characterizing the antigenicity of different H1N1 strains although considerable antigenic differences exist between them, largely due to their swine, avian or human origins Lubeck & Gerhard, 1981; Robertson & Engelhardt, 2010) . More recently, the antigenicity of the influenza A (H1N1) pdm09 virus has been reported (Hancock et al., 2009; Steitz et al., 2010) . Of note, most of the early influenza escape mutant studies were carried out using viruses grown in hen egg allantoic fluid as a source of antigen (Laver & Webster, 1976; Wood & Williams, 1998 ).
However, host-adaptation mutations have frequently been reported when a virus is egg adapted (Robertson et al., 1993 (Robertson et al., , 1995 . Moreover, post-translational modifications, mainly glycosylation and disulfide bridging, are different in mammalian eukaryotic systems as compared with egg-, bacteria-, yeast-or plant-derived antigens. These post-translational modifications of the viral antigen may lead to alteration of phenotypic and potentially immunogenic properties of the HA protein (Hart, 1997; Hausmann et al., 1997) .
In this study, we created a panel of mAbs against the HA protein of A/California/04/2009 (pdm09) and A/Brisbane/ 59/2007 (Bris07) viruses expressed in human cells. We then mapped the escape mutant epitopes, which provide valuable information not only on eventual drifts but also for vaccine improvement.
RESULTS

Comparison of HA antigenic sites demonstrates a significant shift in 2009
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Immunoenzymatic properties of mAbs reveal differential specificities towards H1-pdm09 and H1-Bris07
Screening of hybridomas using ELISA, haemagglutinin inhibition assays (HAIs) and Western blot analysis enabled us to select a total of 33 mAbs (Table 3) . These included 20 mAbs obtained from the mice immunized with the pdm09 antigens (H1-pdm09 mAbs) and 13 mAbs obtained with the Bris07 antigens (H1-Bris07 mAbs). In homologous ELISA experiments, all H1-pdm09 mAbs and H1-Bris07 mAbs tested positive against their respective virus antigen. In heterologous ELISA experiments testing H1-pdm09 mAbs versus Bris07 antigen and H1-Bris07 mAbs versus pdm09 antigen, 15 H1-pdm09 mAbs were specific for pdm09, five H1-Bris07 mAbs were specific for Bris07 and the remaining 13 mAbs (five H1-pdm09 and eight H1-Bris07) were cross-reactive.
Generation of escape mutants from mAbs expressing high binding affinity
After four passages in Madin-Darby canine kidney (MDCK)a2,6 cells of either WT pdm09 or Bris07 viruses grown in presence of high concentrations of a single mAb, a total of 24 escape mutants (17 for pdm09 and seven for Bris07) were generated ( (Tables 5  and 6 ). All tested escape mutants but one (V3P6) were not neutralized by their corresponding mAb, whereas the WT virus was neutralized at titres ranging from 1/16 to .1/256. Escape mutants from pdm09 and Bris07 viruses, along with WT viruses, were tested by ELISA using the respective selecting mAb (Fig. 1) . The related histogram demonstrated a general decrease of mAb recognition in presence of the respective escape mutants. Nonetheless, they were not affected to the same extent. Apart from the control, it was expected that V1A5 would react equally with both the mock escape and the WT. We also noticed that V14D11(2) was still capable of recognizing its corresponding mAb, and similarly, V3E6 and V7B2 also reacted with their mAb.
HA protein sequence analysis of escape mutants revealed single or double mutations inside and outside predicted antigenic sites of A/PR/8/1934
Sequencing of the HA gene revealed that 15 pdm09 escape mutant variants obtained with our mAbs contained a single HA amino acid substitution, whereas the other two variants had two HA mutations (Table 7) . Of note, no HA mutations were found in viruses not subjected to mAb pressure. The T89R mutation, within the Cb antigenic site, was found in the V2F8, V7B6 and V14D11 variants. The F128L mutation (between the Cb and Sa antigenic sites) was identified in variants V5A2 and V14B1, whereas the K256E mutation (2 aa from Ca1 antigenic site) was identified in V2H2, V3E6 and V8B10 variants. Escape mutants bearing mutations G157E (Ca2 antigenic site), G172E/ N173D/ K180E (Sa antigenic site), A212E (Sb antigenic site), R269K (15 aa from the antigenic site Ca1) and G478E (within HA2) were isolated once with different mAbs. In total, six of the 11 (54 %) mutations were located within known antigenic sites, including three of six (50 %) in the Sa antigenic site. The N311T escape mutation was obtained alone in V4E3 and V9G6 variants, and as an accompanying mutation in V2F12 and V14D11(2) variants, as well as with highly diluted (1/10 000) anti-pdm09 ferret hyperimmune sera (FHS) (Abed et al., 2011). Sequencing of the HA gene revealed the presence of seven Bris07 escape mutant variants (Table 7) . Three mAbs (3P6, 6B3 and 6B5) induced the same N203D mutation (Sb antigenic site), either alone as in V3P6, or accompanied by an additional A231T mutation as for V6B3 and a H54N substitution in V6B5. With the exception of the N203D mutation (Sb antigenic site), all Bris07 escape mutations were found outside of predicted antigenic sites. For both pandemic and seasonal escape variants, the NA gene was sequenced to identify possible mutations that contributed to the new phenotypes. However, we did not find a NA mutation in any of the escape mutant variants listed in Table 7 , except for V3D11, which harboured the T413P mutation in the NA gene.
Escape mutations are found on the surface of the HA1 subunit protein
The antigenic sites are located on the HA1 subunit of the HA protein.
The vast majority of our escape mutations 
2, Negative result. *A positive (+) result is a difference between mAb and negative control of at least two antibody dilutions. DA positive (+) result indicated by a band at the appropriate molecular-weight size marker. dMN, Microneutralization assay. A positive (+) result is a difference between mAb and negative control of at least two antibody dilutions. §A positive (+) result is an A 450 value .0.2 and more than three times that of the negative control value.
listed in Table 7 except one for pdm09 variants (G478E) and one for Bris07 variants (K464E) were located within the HA1 protein subunit. In Fig. 2 , the escape mutations reported in Table 7 were mapped onto the tertiary structure of the HA1 protein subunit. The ten escape mutations identified among the pdm09 variants and six escape mutations identified among the Bris07 variants are shown in Fig. 2 (a) and (b), respectively. These mutations are clearly exposed on the surface and, if not within the antigenic sites, they are in close proximity to them (Fig. 2c) .
Prevalence of escape mutations in circulating viral strains
The frequency of HA escape mutations found in the NCBI database using the basic local alignment search tool (BLAST) is reported in Table 8 . For pdm09 viruses, the most frequently found mutations were 157E, 172E, 173D and 180E, which were detected between 15 and .50 times. The 212E mutation was found six times in human strains and 11 times in swine strains, whereas all other mutations were found in five strains or fewer. Two of them, 89R and 311T were found only in swine-reported isolates and four (128L, 212E, 256E and 269K) were reported in both human and swine strains. The HA2 mutation 478E was found in two human strains only. For Bris07 viruses, three escape mutations (203D, 231T and 314I) were frequently found in more than 50 seasonal H1N1 strains, whereas all other mutations were not found in any other strain. Another BLAST analysis on NCBI database aimed at finding concomitant escape mutations did not identify more than two mutations on any strain. Only A/Moscow/01/2009(H1N1) contained two escape mutations (172E and 173D). For the seasonal Bris07 strain, no concomitant mutations were found in any strain.
DISCUSSION
Characterizing the influenza HA antigenic sites may provide important information related to influenza drifts and vaccine efficacy. For such purposes, escape mutants induced by mAbs could serve as valuable biological tools. In this study, we intended to generate a panel of mAbs and establish an epitope map for recent pandemic and seasonal influenza H1N1 viruses using the escape mutants approach. Our analysis of the HA antigenic sites from different pandemic and seasonal influenza H1N1 viruses highlighted the magnitude of the 2009 pandemic shift (Table 1) . We also confirmed the identity gap of both viruses in term of antigenic sites with the reference strain A/PR/8/1934. *Antigenic sites Cb, Sa, Ca2, Sa, Ca1 and Sb are as initially described (Caton et al., 1982) . DH1 amino acid numbering of the uncleaved H1 protein starting at first methionine (start codon) (Igarashi et al., 2010) . ||VFHS is an escape mutant virus obtained with the use of polyclonal antibodies from hyperimmuned anti-pdm09 ferret serum. VPBS is a WT virus grown in the absence of mAb (PBS only), serving as negative control. #V10E5 is a WT virus grown in the presence of mAb 10E5 that does not recognize pdm09, serving as negative control.
HA escape mutants in influenza A (H1N1) viruses
Most neutralizing antibodies elicited during influenza infection or vaccination target immunodominant epitopes on the globular head region of the HA protein, which leads to specific strain protection (Benjamin et al., 2014) . In our study, we focused on mAbs that demonstrated a significant HAI and neutralizing activity against Bris07 and pdm09 HA proteins. Despite the fact that all mAbs tested positive in homologous ELISA experiments (Table 3 ), a few of them exhibited negative results in either HAI assays or Western blot analysis; this could be explained by specific (c) The five antigenic sites, Ca1, Ca2, Cb, Sa and Sb, of the H1 molecules as previously described on A/PR/8/1934 (Caton et al., 1982) are shown. The figure was generated using PyMol Molecular Graphic Systems (version 1.2r1).
and non-specific biochemical properties such as their heavy-chain composition (isotype), glycosylation status and the regions to which they are directed. The fact that the pdm09 HA was able to generate a higher number of specific mAbs than Bris07 supports the idea that the new epitopes brought by this virus during the 2009 pandemic are more immunogenic than the old epitopes already present on the seasonal virus.
The ability of neutralizing mAbs to select for escape mutants that harbour punctual mutations on the antigenic sites has been reported previously (Caton et al., 1982; Lubeck & Gerhard, 1981; Webster et al., 1982) . In this study, we sought to determine if all neutralizing mAbs could induce the emergence of escape mutants. Our results in Tables 3 and 4 show that only 14 among the 20 pdm09 and six among the 13 Bris07 neutralizing mAbs induced escape mutants in at least three experimental attempts. In order to assess the influence of the binding affinity on the emergence of escape mutants, we used the SKI Pro interferometry system for the determination of K d values. The mAbs that were associated with the emergence of escape mutants demonstrated a relatively high affinity as the K d values were found to be within the nanomolar range (Malarchuk & Irvin, 2010) . However, we failed to generate escape mutants using 1B6 (an IgG1) and 7B7 (an IgM) mAbs despite displaying high-affinity binding activity.
Thus, it appears that neutralizing activity and high-affinity binding may not be the only factors involved in the in vitro selection of escape mutants. For instance, as frequently reported, the high error mutation rate in the polymerase of RNA viruses is probably a significant factor determining the existence or appearance of the escape mutants during these types of in vitro experiments (Domingo & Holland, 1997) . A reason for which not all high-affinity neutralizing mAbs were able to generate escape mutants could be explained by the fact that some mutations are too functionally important. These type of mutations would generate defective particles that will never outgrow the WT fully functional virus. Testing of the escape mutant viruses versus the WT pdm09 or Bris07 viruses against the mAbs as shown in Tables 5 and 6 (MN) and Fig. 1 (ELISA) gave similar results. Indeed, much lower results in neutralization-inhibition (MN) and A 450 (ELISA) values were obtained for the escape mutant viruses than for their respective WT viruses. However, the lack of antibody recognition was more obvious using the MN assay than the ELISAs. The latter is probably due to the similarity between the MN assay and the protocol used to generate escape mutants, which basically relies on neutralization inhibition as the selective parameter.
As shown in Table 7 , of the 11 escape mutations identified within the HA protein (HA1 and HA2) in our pdm09 (Brownlee & Fodor, 2001; Caton et al., 1982; Lubeck & Gerhard, 1981) . Importantly, eight new escape mutations (T89R, F128L, G157E, K180E, A212E, R269K, N311T and G478E) were generated for the first time to our knowledge. Four of these newly identified mutations (T89R, G157E, K180E and A212E) are part of recognized antigenic sites, i.e. Cb, Ca2, Sa and Sb, respectively. The G172E mutation has been reported previously in several studies O'Donnell et al., 2012; Rudneva et al., 2012) whereas the mutation N173D has only been reported by a single group (Rudneva et al., 2012) . These two mutations and our newly found K180E mutation are part of the Sa antigenic site. The latter site gave rise to three different escape mutants, suggesting that this site offered higher immunogenic diversity within the immunized mice. We could anticipate that a small molecule distortion could expose to the immune system residues at the extremity of an antigenic site such as for escape mutation K256E (2 aa from Ca1 site); however, it is harder to anticipate an epitope exposition of F128L (16 aa from Cb site and 13 aa from Sa site) or R269K (14 aa from Ca1 site).
The complete HA protein of H1N1 viruses is 566 aa and this is cleaved into the HA1 subunit (338 aa) and the HA2 subunit (228 aa). Thus, the HA2 mutation found with mAb 2F8 (G478E, prior to cleavage) is located at aa 140 of the HA2. This site is located in the HA2 stem farther than the reported conserved sites (K51, D109 and D112) that are responsible for membrane fusion (Thoennes et al., 2008) .
The low number of mAbs generated against the seasonal Bris07 virus may constitute a limitation of our study. As shown in Table 7 , we obtained eight different mutations at seven different residues in our Bris07 escape mutants. Only one escape mutation (N203D) was located within the antigenic site Sb for three of the escape variant viruses (V3P6, V6B3 and V6B5). Notably, to our knowledge, all eight escape mutations (H54N, N55D, N55K, L60H, N203D, A231T, V314I and K464E) in the Bris07 background have not been reported. Unlike the Sa antigenic site in pdm09 background variants, the Sb site in Bris07 background variants does not seem to show immunogenic diversity, but rather a single immunodominant amino acid (N203D) that was targeted by three different hybridomas.
In our study, we did not find mutations on the same residue for both pdm09 and Bris07 HA; however, we generated an escape mutation N203D for the Bris07 HA and another group of investigators generated similar and nearby escape mutations (A203T and D204E) from their local pdm09 virus (Yasugi et al., 2013) . Thus, aa 203 appears as a potential target for neutralizing both seasonal and pandemic viruses simultaneously. The Bris07 mutation on HA2 (K464E, prior to cleavage) selected with mAb 3D11, is located at aa 126 of the HA2 protein after cleavage. This position is also located on the HA2 stem subunit, farther than the conserved sites responsible for fusion with host cell membrane (Thoennes et al., 2008) . However, this amino acid is located closer to these important sites than the HA2 mutation (G478E) found in pdm09. Interestingly, the escape mutant V3D11 was also the only virus with a mutation in the NA gene (T413P), which may compensate for an unfavourable HA2 mutation. Moreover, this mAb (3D11) also showed the highest affinity of all neutralizing mAbs with a low K d value of 0.2 nM (Table 4) .
Usually, escape mutation experiments performed with mAbs generate one, two or three amino acid changes. These mutations occur most commonly at the direct site of attachment of the mAb, but they may also consist of mutations due to host adaptation (Robertson et al., 1993) . However, in such a situation, these variants would not affect ELISA test results since the epitope would not be lost.
Another possibility is the emergence of compensatory mutations that occur in an attempt to keep viral fitness (Abed et al., 2014) . The fact that N311T was the only mutation reported when diluted hyperimmune sera was used and that five mAb variants contained this mutation, suggests that it might be a strategic mutation allowing the HA to take a very different antigenic conformation and to evade mAb pressure by revealing new epitopes.
Although the primary amino acid sequences in Table 7 showed mutations at three very different regions of the HA1 molecule, i.e. the start of the protein region (54-60 aa), the antigenic sites region (87-254 aa), and the far end of the protein region (beyond 300 aa), the threedimensional positioning of those mutations highlights mainly two regions as shown on Fig. 2 . One region comprised a small cluster of mutations, including not only H54N, N55D, N55K and L60H mutations, but also N311T and V314I mutations as well, which represent the start and the end of the protein stem. The other region comprised a large cluster of mutations representing the globular head encompassing previously reported antigenic sites and all other HA1 mutations. Moreover, such epitope mapping localized mutations inside and outside of the antigenic sites at positions that are accessible to antibodies. Our BLAST analysis provided valuable information on eventual drifts. For instance, it suggests that the substitutions T89R and N311T in the pdm09 background, so far reported only in swine viruses, could be eventually transferred to humans highlighting the need for constant surveillance efforts.
To summarize, we obtained a panel of mAbs against the pdm09 and Bris07 HA proteins, using mammalian cells for both antigen production and escape mutants generation. Forty-five per cent of the pdm09 escape mutations and 87.5 % of the Bris07 escape mutations were located outside the reference antigenic sites of A/PR/8/1934 (H1N1). Thus, due to the heterogeneity of H1N1 HA proteins, additional strains should be antigenically characterized in order to refine and update the epitopes defining the antigenic sites. Such information will help in the design of cross-reactive vaccines. Our results could also be used to improve biomathematical models aimed at predicting strain variability. (Deem & Pan, 2009; Lee & Chen, 2004 (Hatakeyama et al., 2005) and purified by sucrose gradients (Arora et al., 1985; StahlHennig et al., 1992 Immunoenzymatic screenings. Hybridomas were screened with ELISA using Maxisorp 96-well plates (Thermo Fisher Scientific) that were coated overnight with 50 ml 10-50 ng of either pdm09 or Bris07 whole-inactivated viruses into carbonate buffer (pH 9.6). Plates were washed three times with PBS/Tween 0.05 % (PBS-T) and saturated with 5 % BSA for 3 h at room temperature. Plates were washed again five times with PBS-T and 50 ml hybridoma culture supernatant was then added to each well for 1 h at room temperature. After seven washes with PBS-T, 50 ml of a 1/2500 dilution of HRP-conjugated anti-mouse IgG HRP (H+L) (Promega) was added to the wells for 1 h. Plates were washed seven times with PBS-T and then 50 ml TMB substrate (TMB, 3,39,5,59-tetramethylbenzidine; Fitzgerald Laboratories) was added for 10 min and the reaction was stopped by adding 50 ml H 2 SO 4 2M solution. The A 450 was read with a spectrophotometer for 0.1 s. Putative positive wells containing the desired hybridoma were identified as wells having both an A 450 .0.2 and more than three times that of the negative control value. Hybridomas that tested positive against the whole virus and the recHA by ELISA were subsequently analysed by HAI (WHO, 2002) . For ELISA testing on escape mutants and their WT counterparts, the same protocol was used except that plates were coated in triplicate with 32 HA units of viral antigen as the first step.
Western blotting. Five micrograms of sucrose-gradient purified virus proteins from A/Quebec/144147/2009 or A/Brisbane/59/2007 was separated on a 12 % SDS-PAGE gel (Arora et al., 1985; Laemmli, 1970) and transferred to a nitrocellulose membrane (Towbin et al., 1992) . Strips of nitrocellulose were saturated with 7 % milk in TBS containing 0.1 % Tween-20 (TBS-T) for 2 h at room temperature. Strips were washed three times with TBS-T and incubated with 5 ml hybridoma culture supernatant/TBS-T with 0.2 % milk (1 : 1, v/v). After two washes of the strips with TBS-T, 5 ml TBS-T with 0.1 % milk with anti-IgG mouse (H+L) HRP conjugated (1/2500 dilution in PBS) was added for 1 h at room temperature. Strips were washed as mentioned previously and revealed with TMB substrate (W4121; Promega).
Microneutralization. For the MN assays, TCID 50 viral titres were determined in MDCKa2,6 cells. mAbs were twofold serially diluted in PBS with 1 TCID 50 dose of virus. The plates were incubated for 1 h at room temperature to allow for virus-antibody interaction. The contents of each well were then transferred onto microtitre plates with confluent monolayers of MDCKa2,6 cells. After 1 h of further incubation at 37 uC, the virus/mAbs mixture was removed and each well was washed twice with 150 ml PBS. After the last wash, 200 ml infection medium containing high-glucose Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 2 mg TPCK-treated trypsin (L-1-tosylamido-2-phenylethyl chloromethyl ketone) ml 21 , 0.1 % BSA and 16 HEPES and antibiotics was added. The plates were further incubated at 37 uC in 5 % CO 2 and cytopathic effects (CPE) were monitored for 7 days post-inoculation. The MN titre was defined as the inverse of the serum dilution immediately preceding the wells exhibiting CPE (Skowronski et al., 2014) .
Evaluation of binding affinities by K d determination. The binding affinity of the different mAbs was evaluated with optical interferometry using the SKI Pro instrument (Silicon Kinetics). The isotype of the mAbs was first determined with an isotyping kit (Rockland). Then, mAbs were purified with AcroSep Protein A HyperDF-1 ml columns (PALL Life Science). The mAbs were then dialysed using Nanosep 10K Omega columns (PALL Life Science) and PBS as matrix buffer. As a first step, 5 mg recombinant HA was immobilized on the sample channel and 5 mg BSA was immobilized on the reference channel of a carboxychip (Silicon Kinetics). Immobilization took place at 6 ml min 21 for 7 min followed by quenching with 1 M ethanolamine pH 8.5 (Silicon Kinetics) and reequilibration in H 2 O. The chip was then equilibrated with PBS for 10 min and 90 ml mAbs diluted in PBS at 0.1 mg ml 21 was passed through both sample and reference channels at 10 ml min 21 and this was followed by a 6 h dissociation period. The optical displacement difference in nanometers between both channels allowed for the establishment of a binding curve followed by a dissociation curve. The SKI Pro software algorithm was used to calculate K on , K off and K obs values, from which a K d value was estimated (Latterich & Corbeil, 2008; Sanchez et al., 2010; Stephan et al., 2014) .
Generation of escape mutants and epitope mapping. The WT pdm09 and Bris07 viruses were immunocomplexed with different mAbs by mixing 50 ml twofold serial dilutions of virus in PBS with 50 ml undiluted hybridoma supernatant for 30 min at room temperature. Ninety-six-well plates containing MDCKa2,6 cells were washed twice with PBS and adsorbed with the immunocomplexed viruses at 37 uC in 5 % CO 2 for 30 min. Three washes with 150 ml PBS per well were performed to remove unadsorbed viruses, then 200 ml infection medium (see above) was added to each well followed by an incubation step of 3-7 days at 37 uC in 5% CO 2 . Wells corresponding to the highest viral dilution giving CPE were selected. These steps of escape mutant selection were repeated twice in order to enrich the escape mutant viral population. At the fourth and last passage, infection was performed in a six-well plate and three to five aliquots of 1 ml containing escape viral mutants were frozen at 280 uC. Aliquots of 150 ml infected cell culture supernatant were extracted using an RNA extraction kit (Qiagen) followed by a reversetranscription step with the Superscript II (Life Technologies). The PCR was performed with Taq DNA polymerase (Life Technologies) and HA/NA-specific primers (primer sequences available upon request). PCR products of the HA and NA genes were sequenced (3730xl DNA analyser; Applied Biosystems). The sequences were aligned using CLC Sequence viewer (v.6.6.2; Prismet). The mutations were mapped onto the three-dimensional structure of the HA1 [Protein Data Bank (PDB) ID 3AL4], available on the RCSB-PDB website (http://www.rcsb.org/pdb/home/home.do). Finally, the PyMOL Molecular Graphics System (version 1.2r1; Schrödinger) was used to highlight the three-dimensional location of the main HA mutations identified in this study (Yiu & Chen, 2014) .
Mutation prevalence and BLAST analysis. The identified escape mutations were inserted in the middle of a 10 aa sequence stretch of either pdm09 or Bris07 HA proteins. The mutated sequences were then searched using the BLAST database (NCBI). Complete H1 proteins from pdm09 and Bris07 viruses containing all escape mutations identified in this study were also analysed in BLAST for identification of similar reported strains.
